Ghent, Belgium

Veronique De Brabandere

This inventor holds 5 USPTO granted patents and 6 published patent applications and 8 EPO patents. Top assignee: Ablynx N.v.. Active years: 2015-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Veronique De Brabandere. Retrieved from https://idiyas.com/inventor/veronique-de-brabandere

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.4

ph-index = 2

Forward Citations = 8(Granted Patents)


Location History:

  • Gent, BE (2016)
  • Ghent, BE (2015 - 2018)

Company Filing History:


Years Active: 2015-2026

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Veronique De Brabandere: Innovator in Immunoglobulin Formulations

Introduction

Veronique De Brabandere is a prominent inventor based in Ghent, Belgium. She has made significant contributions to the field of immunology, particularly in the development of stable formulations of immunoglobulin single variable domains. With a total of 5 patents to her name, her work has the potential to impact pharmaceutical and diagnostic preparations significantly.

Latest Patents

One of her latest patents is titled "Stable formulations of immunoglobulin single variable domains." This invention relates to stable formulations of polypeptides, specifically immunoglobulin single variable domains directed against von Willebrand Factor (vWF). The formulations are designed to remain stable during prolonged storage and across a wide range of temperatures. They ensure high stability of the polypeptide, allowing for multiple freeze-thaw cycles without deterioration, and provide resilience against mechanical stress. This innovation is particularly suitable for pharmaceutical applications and is compatible with acceptable diluents.

Another notable patent is the "Method for producing solid formulations comprising immunoglobulin single variable domains." This patent outlines methods for preparing solid formulations by contacting solid carriers with a liquid containing the immunoglobulin single variable domains. The process involves agitating the carrier and exposing the mixture to heat to evaporate the liquid, resulting in granulation or coating of the carrier.

Career Highlights

Veronique De Brabandere is currently associated with Ablynx N.V., a company known for its innovative approaches in biopharmaceuticals. Her work at Ablynx has been instrumental in advancing the development of therapeutic solutions based on her patented formulations.

Collaborations

Throughout her career, Veronique has collaborated with several talented individuals, including Ann Brige and Christine Labeur. These collaborations have fostered a creative environment that encourages innovation and the development of groundbreaking solutions in the field of immunology.

Conclusion

Veronique De Brabandere's contributions to the field of immunology through her patents and work at Ablynx N.V. highlight her role as a leading inventor. Her innovations in stable formulations of immunoglobulin single variable domains are paving the way for advancements in pharmaceutical and diagnostic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…